RxDoctor Payments Data

Nadine Halliburton-Foster, MD

Family Medicine · Cumming, GANPI 1578596029

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $209,733 of the $218,554 with a category attached, or 96.0%. Takeda Pharmaceuticals U.S.A., Inc. accounts for 96.0% of it on its own, with 5 other manufacturers making up the rest. Among family medicine clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$218,554in general payments, 2019–2025

Across 143 payments — averaging $1528.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Takeda Pharmaceuticals U.S.A., Inc.$210K
  • Genentech USA, Inc.$9K
  • Paratek Pharmaceuticals, Inc.$114
  • Aytu Biopharma, Inc.$16
  • Pfizer$15
  • Merck$15

What the payments were for

  • Consulting fees$209,73396%
  • Speaking & faculty fees$6,3303%
  • Travel & lodging$1,7881%
  • Food & beverage$7030%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$218,554 in reported general payments places this provider in the 95th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$76,881
Medicare patients
209
Services billed
3,495

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
PaxlovidNirmatrelvir/Ritonavir31$2,859
Cefdinir78$1,236
Albuterol Sulfate HfaAlbuterol Sulfate33$1,001
Doxycycline Hyclate37$299
Prednisone148$229
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst19$229
Diclofenac Sodium26$146
Azithromycin44$141
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav20$128
Cephalexin16$78
Amlodipine Besylate11$40
Amoxicillin14$39
Ciprofloxacin Hcl11$23
Fluconazole13$21

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerPaxlovid$15$2,85931 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Cumming

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →